News

On May 13, 2026, Judge Stanley Chessler of the United States District Court for the District of New Jersey granted final approval to a $4.85 million common fund settlement in Huertas et al. v. Bayer U.S. LLC et al., Case No. 2:21-cv-20021. The case involved the alleged benzene contamination of Lotrimin and Tinactin foot spray products. The settlement, the largest class action settlement involvi...

On October 17, 2025 Judge Heidi A. Benson of the Circuit Court for the County of McDonough, State of Illinois granted final approval of the class action settlement in Farwell v. Google LLC. Bursor & Fisher filed the lawsuit in 2020 alleging BIPA privacy violations on behalf of Illinois students using Google's Workspace for Education platform. The settlement provides an $8.75 million cash common ...

On September 30, 2025, the Honorable Victor A. Bolden, United States District Court Judge for the District of Connecticut, largely denied Defendant Pennymac Loan Services's motion to dismiss in Cyrus v. Pennymac Loan Services, 3:24-cv-01145 (D. Conn). Bursor & Fisher, P.A. represents James Cyrus, a U.S. Army and Vietnam War military veteran in a putative class action against Pennymac, a Veterans ...

On May 28, 2025, Judge Analisa Torres of the United States District Court for the Southern District of New York appointed Bursor & Fisher, P.A. as interim co-lead counsel in the matter titled In re L’Oréal Benzoyl Peroxide Products Litigation, Case No. 24 Civ. 3137. The lawsuit alleges that certain CeraVe branded acne cream and gel products formulated with benzoyl peroxide are improperly...

On April 28, 2025, Judge J. Brendan Day of the United States District Court for the District of New Jersey appointed Philip L. Fraietta of Bursor & Fisher, P.A. to serve as Plaintiffs' interim co-lead class counsel in the matter titled In re Kenvue BPO Products Liability Litigation, Case No. 24-4109. The lawsuit alleges that certain Neutrogena branded acne cream and gel products formulate...

On June 12, 2025, the Honorable Lizette Colon of the Supreme Court of New York, County of Richmond issued an Order denying Defendant's Motion for Summary Judgment in the case captioned Cammayo v. 1and8, Inc. d/b/a Museum of Ice Cream, Index No. 150173/2024 (N.Y. Sup. Ct. Richmond Cnty.). Plaintiff alleges the Museum of Ice Cream violated New York Arts & Cultural Affairs Law § 25.07(4) by fai...

While Ozempic (semaglutide) doesn’t cause heart problems per se, research has found a link between the use of Ozempic and some heart issues that could give patients a cause for concern. This new research had made some people interested in semaglutide medications cautious about taking GLP-1 drugs given the potential health risks. Yet Ozempic, Wegovy, Zepbound, and similar medications continue to ...

Ozempic (semaglutide) doesn’t directly cause headaches in patients, but the GLP-1 medication can contribute to a headache given how the drug affects the body. In fact, popular type 2 diabetes and weight loss drugs like Ozempic have been linked to a number of mild to severe health issues. It’s the reason some patients have been cautious about taking Ozempic even though GLP-1 medications continu...

On April 9, 2025, the Honorable Algenon L. Marbley, United States District Court Judge for the Southern District of Ohio, issued an unsealed Opinion & Order granting Plaintiff's motion for class certification in Kirkbride v. The Kroger Co., 2:21-cv-00022-ALM-EPD (S.D. Ohio).  Plaintiffs allege that Defendant The Kroger Company overcharged insured consumers for generic prescription medicatio...

On March 19, 2025, the Honorable Kenneth M. Karas of the Southern District of New York issued an Opinion and Order granting Plaintiff's motion for class certification in Newman v. Bayer Corporation, Case No. 7:22-cv-07087 (S.D.N.Y.).  Plaintiff alleges Bayer misrepresented the serving size of its "One A Day" gummy vitamins, such that consumers paid twice as much for the product despite receivin...